Lake Hills Wealth Management »

Regeneron Pharmaceuticals shares owned by Lake Hills Wealth Management

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Lake Hills Wealth Management from 13F filings

Historical chart of Lake Hills Wealth Management investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Lake Hills Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Lake Hills Wealth Management

Quarter filed Position value Share count Share price at filing
2025-03-31 $391k 616 634.23

More positions owned by Lake Hills Wealth Management

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Spdr Series Trust State Street Spd (BIL)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr 0-5 Yr Tips Etf (STIP)
Ishares Tr 3 7 Yr Treas Bd (IEI)
Spdr Series Trust State Street Spd (XME)
Select Sector Spdr Tr State Street Hea (XLV)
Vanguard Index Fds Value Etf (VTV)
Ishares Tr Msci Eafe Etf (EFA)
Ishares Tr Msci Emg Mkt Etf (EEM)
Global X Fds Us Infr Dev Etf (PAVE)
Ishares Silver Tr Ishares (SLV)
First Tr Exchange-traded Nat Gas Etf (FCG)
Alps Etf Tr Alerian Mlp (AMLP)

View all positions for Lake Hills Wealth Management

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
BlackRock
State Street Corporation
Dodge & Cox
Jpmorgan Chase & Co
Geode Capital Management
Franklin Resources
Capital World Investors
Loomis, Sayles and
FMR
Invesco
Susquehanna International
Goldman Sachs Group
Nuveen
Northern Trust

View all funds holding Regeneron Pharmaceuticals